Clinical trial · Observational
Survival, Quality of Life and Resectability in Locally Advanced Pancreatic Cancer
Survival, Quality of Life and Resectability in Locally Advanced Pancreatic Cancer - a Multicenter Prospective Observational Study
NCT05356039CI-TRIAL-00062393SQUARErecruitingClinicalTrials.gov clinicaltrialsProvenance
- Source
- ClinicalTrials.gov
- Retrieved
- Sep 8, 2026
- Layer
- normalized (units and labels harmonized; values unchanged)
- Run
- ING-CLINICALTRIALS-20260908-000001
Summary
Brief summary (as posted)
This study aims to assess overall survival, quality of life and resection rates in locally advanced pancreatic cancer
Conditions
Conditions (9)
Free-text conditions as registered, with the CancerIndex entity they were reconciled to and the match type.
| Condition (as posted) | Mapped entity | Match | Confidence |
|---|---|---|---|
| Borderline Resectable Pancreatic Adenocarcinoma | Pancreatic Adenocarcinoma | CURATED_BROADER | 0.78 |
| Chemotherapy Effect | — | UNRESOLVED | — |
| Locally Advanced Pancreatic Adenocarcinoma | Pancreatic Adenocarcinoma | CURATED_BROADER | 0.78 |
| Pancreas Adenocarcinoma | Pancreatic Adenocarcinoma | ALIAS | 0.90 |
| Pancreas Cancer | Pancreatic Carcinoma | ALIAS | 0.90 |
| Pancreas Disease | — | UNRESOLVED | — |
| Pancreas Neoplasm | Pancreatic Neoplasm | ALIAS | 0.90 |
| Quality of Life | — | UNRESOLVED | — |
| Surgery | — | UNRESOLVED | — |
Interventions
Interventions (0)
Data not yet available
No intervention recorded.
Design
Arms and outcomes
Arms (0)
[]Primary outcomes (2)
- measure
- Median Overall Survival
- timeFrame
- From date of inclusion until the date of death from any cause, assessed up to 72 months
- description
- Median overall survival for patients with locally advanced pancreatic cancer stratified for treatment allocation
- measure
- Resection
- timeFrame
- From the time of inclusion to end of study follow up or date of death from any cause, whichever came first, up to 72 months
- description
- Rates of resection among patients with locally advanced pancreatic cancer stratified for treatment allocation
Secondary outcomes (9)
- measure
- Oncological treatment compliance
- timeFrame
- From the time of inclusion to end of study follow up or date of death from any cause, whichever came first, up to 72 months
- description
Eligibility
Eligibility (as posted)
- Sex
- All
- Minimum age
- 18 Years
Show eligibility criteria text
Inclusion Criteria: * Confirmed or suspected invasive pancreatic primary tumor * Tumor classified as borderline resectable or locally advanced disease according to NCCN guidelines Exclusion Criteria: * Suspected endocrine tumor * Suspected non-pancreatic periampullary tumor * Distant metastasis * Age \< 18 years * Patient unable to understand verbal or written information interfering with informed consent or treatment * Mental or organic disorder interfering with informed consent or treatments
References
Publications (0)
Data not yet available
No reference posted for this study.